Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Partial Thromboplastin Time"" wg kryterium: Temat


Tytuł:
An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.
Autorzy:
Berk ZBK; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Shah A; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Sun W; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Griffith BP; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Wu ZJ; Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Artificial organs [Artif Organs] 2022 Mar; Vol. 46 (3), pp. 501-505. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:
Journal Article
MeSH Terms:
Partial Thromboplastin Time*
Whole Blood Coagulation Time*
Anticoagulants/*administration & dosage
Heparin/*administration & dosage
Animals ; Dose-Response Relationship, Drug ; Linear Models ; Models, Animal ; Sheep
Czasopismo naukowe
Tytuł:
A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.
Autorzy:
Hazim AZ; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Ruan GJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Khodadadi RB; Division of Infectious Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Slusser JP; Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
Marshall AL; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Pruthi RK; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2022 Feb; Vol. 44 (1), pp. 209-215. Date of Electronic Publication: 2021 Oct 05.
Typ publikacji:
Journal Article
MeSH Terms:
Ambulatory Care Facilities*
Partial Thromboplastin Time*/methods
Partial Thromboplastin Time*/standards
Prothrombin Time*/methods
Prothrombin Time*/standards
Blood Coagulation Disorders/*blood
Blood Coagulation Disorders/*diagnosis
Adult ; Aged ; Blood Coagulation Disorders/etiology ; Blood Coagulation Tests/methods ; Blood Coagulation Tests/standards ; Clinical Decision-Making ; Disease Management ; Female ; Humans ; Male ; Middle Aged ; Outpatients ; Reference Values ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Effect of microwave ablation on platelet and coagulation function in patients with BCLC-A hepatocellular carcinoma.
Autorzy:
Zhao W; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Li H; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Li W; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Guo J; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Cai L; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Duan Y; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hou X; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Diao Z; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Shao X; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Du H; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Li W; Department of Hepatology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Li C; Department of Oncology Interventional Radiology, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2021 Nov; Vol. 17 (5), pp. 1275-1280.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Coagulation*
Partial Thromboplastin Time*
Blood Platelets/*physiology
Carcinoma, Hepatocellular/*surgery
Liver Neoplasms/*surgery
Microwaves/*therapeutic use
Radiofrequency Ablation/*methods
Adult ; Aged ; Blood Coagulation Tests ; Carcinoma, Hepatocellular/pathology ; Female ; Fibrin Fibrinogen Degradation Products/metabolism ; Follow-Up Studies ; Humans ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Haematological variables and risk of future venous thromboembolism in the British Regional Heart Study on men. Combined D-dimer and APTT as a predictive test for thromboembolism?
Autorzy:
Wannamethee SG; Department of Primary Care and Population Health, UCL, Royal Free Campus, London, UK.
Papacosta O; Department of Primary Care and Population Health, UCL, Royal Free Campus, London, UK.
Lennon L; Department of Primary Care and Population Health, UCL, Royal Free Campus, London, UK.
Whincup PH; Population Health Research Institute, St George's, University of London, London, UK.
Rumley A; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Lowe GDO; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (3), pp. 587-594. Date of Electronic Publication: 2022 Jun 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Fibrin Fibrinogen Degradation Products*/chemistry
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Biomarkers ; Humans ; Male ; Obesity ; Partial Thromboplastin Time ; Risk Factors
Czasopismo naukowe
Tytuł:
A multi-laboratory assessment of lupus anticoagulant assays performed on the ACL TOP 50 family for harmonized testing in a large laboratory network.
Autorzy:
Favaloro EJ; Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.; Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia.; Faculty of Science and Health, Charles Sturt University, Wagga Wagga, New South Wales, Australia.
Mohammed S; Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
Vong R; Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.
Chapman K; Haematology, NSW Health Pathology, John Hunter Hospital, Newcastle, New South Wales, Australia.
Swanepoel P; Haematology, NSW Health Pathology, John Hunter Hospital, Newcastle, New South Wales, Australia.
Kershaw G; Haematology, NSW Health Pathology, Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Cai N; Haematology, NSW Health Pathology, Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Just S; Haematology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Connelly L; Haematology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Brighton T; Haematology, NSW Health Pathology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Pasalic L; Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia.; Sydney Centres for Thrombosis and Haemostasis, Westmead, New South Wales, Australia.; University of Sydney, Westmead, New South Wales, Australia.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2022 Jun; Vol. 44 (3), pp. 654-665. Date of Electronic Publication: 2022 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Antiphospholipid Syndrome*
Lupus Coagulation Inhibitor*
Blood Coagulation Tests/methods ; Humans ; Laboratories ; Partial Thromboplastin Time ; Prothrombin Time/methods
Czasopismo naukowe
Tytuł:
Comparison of capillary and venous blood sampling for routine coagulation assays.
Autorzy:
Fliervoet LAL; Central Diagnostic Laboratory, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands. Electronic address: .
Tiel Groenestege WM; Central Diagnostic Laboratory, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
Huisman A; Central Diagnostic Laboratory, University Medical Center Utrecht and University Utrecht, Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Clinical biochemistry [Clin Biochem] 2022 Jun; Vol. 104, pp. 30-35. Date of Electronic Publication: 2022 Feb 03.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Coagulation*
Phlebotomy*
Blood Coagulation Tests ; Fibrinogen/analysis ; Humans ; Partial Thromboplastin Time
Czasopismo naukowe
Tytuł:
A Comparative Cross-Sectional Study of Coagulation Profiles and Platelet Parameters of Schistosoma mansoni-Infected Adults at Haik Primary Hospital, Northeast Ethiopia.
Autorzy:
Bisetegn, Habtye (AUTHOR)
Feleke, Daniel Getacher (AUTHOR)
Ebrahim, Hussen (AUTHOR)
Tesfaye, Melkam (AUTHOR)
Gedefie, Alemu (AUTHOR)
Erkihun, Yonas (AUTHOR)
Pokaż więcej
Źródło:
Interdisciplinary Perspectives on Infectious Diseases. 6/27/2022, p1-7. 7p.
Czasopismo naukowe
Tytuł:
Reporting of activated partial thromboplastin time (aPTT): Could we achieve better comparability of the results?
Autorzy:
Bronić A; Clinical Institute of Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.; Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
Margetić S; Clinical Institute of Chemistry, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.; Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.
Coen Herak D; Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.; Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
Milić M; Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.; Department of Clinical Laboratory Diagnostics, University Hospital Centre Osijek, Osijek, Croatia.; Faculty of Medicine, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
Krešić B; Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.; Department of Medical Laboratory Diagnostics, University Hospital Centre Split, Split, Croatia.
Radišić Biljak V; Working Group for Laboratory Coagulation of the Croatian Society of Medical Biochemistry and Laboratory Medicine.; Department of Medical Laboratory Diagnostics, University Hospital 'Sveti Duh', Zagreb, Croatia.
Leniček Krleža J; Department of Laboratory Diagnostics, Children's Hospital Zagreb, Zagreb, Croatia.; Croatian Centre for Quality Assessment in Laboratory Medicine (CROQALM).
Pokaż więcej
Źródło:
Biochemia medica [Biochem Med (Zagreb)] 2021 Jun 15; Vol. 31 (2), pp. 020708.
Typ publikacji:
Journal Article
MeSH Terms:
Partial Thromboplastin Time*
Surveys and Questionnaires*
Croatia ; Humans ; Reference Values
Czasopismo naukowe
Tytuł:
Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study.
Autorzy:
Esmaeel HM; Department of Chest Disease and Tuberculosis, Faculty of Medicine, Sohag University, Sohag, 82524, Egypt. .
Ahmed HA; Department of Clinical and Chemical Pathology, Faculty of Medicine, Sohag University, Sohag, Egypt.
Elbadry MI; Division of Haematology, Department of Internal Medicine, Faculty of Medicine, Sohag University, Sohag, Egypt.
Khalaf AR; Department of Chest Disease and Tuberculosis, Faculty of Medicine, Sohag University, Sohag, 82524, Egypt.
Mohammed NA; Department of Public Health and Community Medicine, Faculty of Medicine, Sohag University, Sohag, Egypt.
Mahmoud HA; Department of Anesthesia and Critical Care, Faculty of Medicine, Sohag University, Sohag, Egypt.
Taha EM; Department of Anesthesia and Critical Care, Faculty of Medicine, Sohag University, Sohag, Egypt.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Aug 01; Vol. 12 (1), pp. 13155. Date of Electronic Publication: 2022 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Coagulation Disorders*
COVID-19*
Blood Coagulation ; Fibrin Fibrinogen Degradation Products ; Humans ; Partial Thromboplastin Time ; Prospective Studies
Czasopismo naukowe
Tytuł:
First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men.
Autorzy:
Nowotny B; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
Thomas D; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
Schwers S; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
Wiegmann S; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
Prange W; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
Yassen A; Bayer AG, Research and Development Pharmaceuticals, Wuppertal, Germany.
Boxnick S; CRS Clinical Research Services Wuppertal GmbH, Wuppertal, Germany.
Pokaż więcej
Źródło:
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jul; Vol. 20 (7), pp. 1684-1695. Date of Electronic Publication: 2022 May 20.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
MeSH Terms:
Anticoagulants*/adverse effects
Factor XIa*
Antibodies, Monoclonal, Humanized/pharmacology ; Dose-Response Relationship, Drug ; Double-Blind Method ; Hemorrhage/chemically induced ; Hemorrhage/drug therapy ; Humans ; Male ; Partial Thromboplastin Time
Czasopismo naukowe
Tytuł:
Pharmacokinetics, pharmacodynamics and safety of BAY 2433334, a novel activated factor XI inhibitor, in healthy volunteers: A randomized phase 1 multiple-dose study.
Autorzy:
Kubitza D; Bayer AG, Wuppertal, Germany.
Heckmann M; Bayer AG, Wuppertal, Germany.
Distler J; ClinStat GmbH, Cologne, Germany.
Koechel A; CRS Clinical Research Services Wuppertal GmbH, Wuppertal, Germany.
Schwers S; Bayer AG, Wuppertal, Germany.
Kanefendt F; Bayer AG, Wuppertal, Germany.
Pokaż więcej
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jul; Vol. 88 (7), pp. 3447-3462. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Cytochrome P-450 CYP3A*
Factor XIa/*antagonists & inhibitors
Area Under Curve ; Dose-Response Relationship, Drug ; Double-Blind Method ; Follow-Up Studies ; Half-Life ; Healthy Volunteers ; Humans ; Male ; Midazolam/adverse effects ; Midazolam/blood ; Midazolam/pharmacokinetics ; Partial Thromboplastin Time ; Single-Blind Method
Czasopismo naukowe
Tytuł:
In Vitro Conditioning of Adipose-Derived Mesenchymal Stem Cells by the Endothelial Microenvironment: Modeling Cell Responsiveness towards Non-Genetic Correction of Haemophilia A.
Autorzy:
Barbon S; Section of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling-TES, Onlus, 35030 Padova, Italy.
Stocco E; Section of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling-TES, Onlus, 35030 Padova, Italy.
Rajendran S; Department of Surgery Oncology and Gastroenterology, University of Padova, 35124 Padova, Italy.
Zardo L; Haematology and Haemophilia Centre, Castelfranco Veneto Hospital, 31033 Castelfranco Veneto, Italy.
Macchi V; Section of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.
Grandi C; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling-TES, Onlus, 35030 Padova, Italy.
Tagariello G; Haematology and Haemophilia Centre, Castelfranco Veneto Hospital, 31033 Castelfranco Veneto, Italy.
Porzionato A; Section of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling-TES, Onlus, 35030 Padova, Italy.
Radossi P; Haematology and Haemophilia Centre, Castelfranco Veneto Hospital, 31033 Castelfranco Veneto, Italy.
De Caro R; Section of Human Anatomy, Department of Neuroscience, University of Padova, 35121 Padova, Italy.; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling-TES, Onlus, 35030 Padova, Italy.
Parnigotto PP; Foundation for Biology and Regenerative Medicine, Tissue Engineering and Signaling-TES, Onlus, 35030 Padova, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jun 30; Vol. 23 (13). Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hemophilia A*/genetics
Hemophilia A*/metabolism
Hemophilia A*/therapy
Mesenchymal Stem Cells*/metabolism
Adult ; Blood Coagulation Tests ; Cell Differentiation ; Cells, Cultured ; Culture Media/metabolism ; Humans ; Partial Thromboplastin Time
Czasopismo naukowe
Tytuł:
Inhaled nebulised unfractionated heparin for the treatment of hospitalised patients with COVID-19: A multicentre case series of 98 patients.
Autorzy:
van Haren FMP; Australian National University, College of Health and Medicine, Canberra, Australia.; Intensive Care Unit, Saint George Hospital, Sydney, Australia.
van Loon LM; Australian National University, College of Health and Medicine, Canberra, Australia.
Steins A; Australian National University, College of Health and Medicine, Canberra, Australia.
Smoot TL; Frederick Health Hospital, Frederick, Maryland, USA.
Sas C; Frederick Health Hospital, Frederick, Maryland, USA.
Staas S; Frederick Health Hospital, Frederick, Maryland, USA.
Vilaseca AB; Service of Haematology and Haemostasis, San Camilo Clinic, Buenos Aires, Argentina.
Barbera RA; Service of Haematology and Haemostasis, San Camilo Clinic, Buenos Aires, Argentina.
Vidmar G; Service of Haematology and Haemostasis, San Camilo Clinic, Buenos Aires, Argentina.
Beccari H; Service of Haematology and Haemostasis, San Camilo Clinic, Buenos Aires, Argentina.
Popilevsky F; Surgical Intensive Care Unit, Coney Island Hospital, Brooklyn, New York, USA.
Daribayeva E; Surgical Intensive Care Unit, Coney Island Hospital, Brooklyn, New York, USA.
Venkatesan B; Surgical Intensive Care Unit, Coney Island Hospital, Brooklyn, New York, USA.
Mozes S; Surgical Intensive Care Unit, Coney Island Hospital, Brooklyn, New York, USA.
Postel R; Surgical Intensive Care Unit, Coney Island Hospital, Brooklyn, New York, USA.
Popilevski N; Surgical Intensive Care Unit, Coney Island Hospital, Brooklyn, New York, USA.
Webb A; Clinical Pharmacology, School of Cardiovascular Medicine & Sciences, King's College, London, United Kingdom.
Nunes Q; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Laffey JG; Anaesthesia and Intensive Care Medicine, School of Medicine, and Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, Biomedical Sciences Building, National University of Ireland Galway, Galway, Ireland.; Department of Anaesthesia, University Hospital Galway, Saolta Hospital Group, Ireland.
Artigas A; Critical Center, Corporació Universitaria Sanitaria Parc Tauli, CIBER Enfermedades Respiratorias, Autonomous University of Barcelona, Sabadell, Spain.
Smith R; Department of Critical Care Medicine, St Vincent's Hospital, Melbourne, Australia.
Dixon B; Department of Critical Care Medicine, St Vincent's Hospital, Melbourne, Australia.
Richardson A; Statistical Consulting Unit, Australian National University, Canberra, Australia.
Yoon HJ; Statistical Consulting Unit, Australian National University, Canberra, Australia.
Page C; Sackler Institute of Pulmonary Pharmacology, King's College London, United Kingdom.
Pokaż więcej
Źródło:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jun; Vol. 88 (6), pp. 2802-2813. Date of Electronic Publication: 2022 Jan 19.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
COVID-19*/drug therapy
Heparin*/adverse effects
Anticoagulants ; Hemorrhage/chemically induced ; Hemorrhage/drug therapy ; Humans ; Partial Thromboplastin Time ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real-World Data: A Pharmacokinetic-Pharmacodynamic Modeling Approach.
Autorzy:
Salem AM; Center for Translational Medicine, Department of Pharmacy Practice, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Niu T; Modeling & Simulations, Vertex Pharmaceuticals, Boston, Massachusetts, USA.
Li C; Fosun Pharma, Princeton, New Jersey, USA.
Moffett BS; Department of Pharmacy, Texas Children's Hospital, Houston, Texas, USA.; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Ivaturi V; Center for Translational Medicine, Department of Pharmacy Practice, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Gopalakrishnan M; Center for Translational Medicine, Department of Pharmacy Practice, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
Pokaż więcej
Źródło:
Journal of clinical pharmacology [J Clin Pharmacol] 2022 Jun; Vol. 62 (6), pp. 733-746. Date of Electronic Publication: 2022 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Heparin*/therapeutic use
Pediatrics*
Anticoagulants/therapeutic use ; Child ; Factor Xa Inhibitors ; Humans ; Infant ; Partial Thromboplastin Time ; Retrospective Studies
Czasopismo naukowe
Tytuł:
High-dose glucocorticoid therapy is associated with shortening of activated partial thromboplastin time and prothrombin time.
Autorzy:
Canovi S; Laboratorio Analisi Chimico-Cliniche e di Endocrinologia, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Pilia A; Laboratorio Analisi Chimico-Cliniche e di Endocrinologia, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Bonelli E; Laboratorio Analisi Chimico-Cliniche e di Endocrinologia, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Bonanno A; Laboratorio Analisi Chimico-Cliniche e di Endocrinologia, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Zaldini P; Laboratorio Analisi Chimico-Cliniche e di Endocrinologia, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Colla R; Laboratorio Analisi Chimico-Cliniche e di Endocrinologia, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Aug; Vol. 43 (4), pp. O186-O189. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji:
Letter
MeSH Terms:
Partial Thromboplastin Time*
Prothrombin Time*
Blood Coagulation/*drug effects
Glucocorticoids/*administration & dosage
Glucocorticoids/*adverse effects
Blood Coagulation Tests ; Humans
Opinia redakcyjna
Tytuł:
In vitro unexpected effects of polyphosphates observed through activated partial thromboplastin time-based clot waveform analysis.
Autorzy:
Ozaki Y; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Wakui M; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
Fujimori Y; Office of Clinical Laboratory Technology, Keio University Hospital, Tokyo, Japan.
Oka S; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Nakamura S; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Kondo Y; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Nakagawa T; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Katagiri H; Clinical Laboratory, Keio University Hospital, Tokyo, Japan.
Murata M; Department of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Aug; Vol. 43 (4), pp. O234-O237. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji:
Letter
MeSH Terms:
Partial Thromboplastin Time*
Blood Coagulation/*drug effects
Polyphosphates/*pharmacology
Blood Coagulation Tests/methods ; Blood Coagulation Tests/standards ; Humans
Opinia redakcyjna
Tytuł:
Role of thromboelastography in the evaluation of septic shock patients with normal prothrombin time and activated partial thromboplastin time.
Autorzy:
Kim SM; Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olimpic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Kim SI; Department of Emergency Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.
Yu G; Department of Emergency Medicine, Gangnam Severance Hospital, Seoul, Korea.
Kim JS; Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olimpic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Hong SI; Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olimpic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Chae B; Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olimpic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Shin YS; Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olimpic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Kim YJ; Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olimpic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Jang S; Department of Laboratory Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
Kim WY; Department of Emergency Medicine, University of Ulsan College of Medicine, Asan Medical Center, 88, Olimpic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jun 04; Vol. 11 (1), pp. 11833. Date of Electronic Publication: 2021 Jun 04.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Partial Thromboplastin Time*
Prothrombin Time*
Shock, Septic/*blood
Shock, Septic/*diagnostic imaging
Thrombelastography/*methods
Aged ; Blood Coagulation ; Blood Coagulation Tests ; Emergency Service, Hospital/statistics & numerical data ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Registries ; Republic of Korea/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Prothrombin time and activated partial thromboplastin time reference intervals in dogs, by gender and age group using the Start®4 (Stago).
Autorzy:
Barbosa, Marta
Pires, Maria João
Queiroga, Felisbina
André Pires, Carlos
Dinis, Tânia
Silvestre-Ferreira, Ana C.
Pokaż więcej
Alternatywny tytuł:
Intervalos de referência para o tempo de protrombina e tempo de tromboplastina parcial ativada no cão de acordo com a idade e o gênero utilizando o Start®4 (Stago).
Źródło:
Ciência Rural. 2022, Vol. 52 Issue 10, p1-7. 7p.
Czasopismo naukowe
Tytuł:
Overall hemostasis potential and aPTT-clot waveform analysis as powerful laboratory diagnostic tools for identification of hemophilia A patients with unexpected bleeding phenotype.
Autorzy:
Milos M; Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
Coen Herak D; Department of Laboratory Diagnostics, University Hospital Centre Zagreb, Zagreb, Croatia.
Mahmoud Hourani Soutari N; Department of Coagulation Research, Institute for Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
Pavic J; Department of Medical Biochemistry and Hematology Laboratory, General County Hospital Livno, Livno, Bosnia and Herzegovina.
Zupancic-Salek S; Department of Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Zadro R; St. Catherine Specialty Hospital, Zabok, Croatia.
Antovic JP; Department of Coagulation Research, Institute for Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Apr; Vol. 43 (2), pp. 273-280. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Coagulation*
Hemostasis*
Partial Thromboplastin Time*/methods
Partial Thromboplastin Time*/standards
Hemophilia A/*blood
Hemophilia A/*complications
Hemorrhage/*diagnosis
Hemorrhage/*etiology
Adolescent ; Adult ; Aged ; Case-Control Studies ; Disease Management ; Disease Susceptibility ; Factor VIII ; Female ; Humans ; Male ; Middle Aged ; Phenotype ; Severity of Illness Index ; Thrombin/metabolism ; Young Adult
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz